PetMed Express Statistics
Total Valuation
PetMed Express has a market cap or net worth of $48.09 million. The enterprise value is $21.83 million.
Important Dates
The next estimated earnings date is Tuesday, June 9, 2026, after market close.
| Earnings Date | Jun 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PetMed Express has 21.37 million shares outstanding. The number of shares has decreased by -0.13% in one year.
| Current Share Class | 21.37M |
| Shares Outstanding | 21.37M |
| Shares Change (YoY) | -0.13% |
| Shares Change (QoQ) | +0.57% |
| Owned by Insiders (%) | 7.54% |
| Owned by Institutions (%) | 28.70% |
| Float | 13.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.26 |
| Forward PS | n/a |
| PB Ratio | 1.50 |
| P/TBV Ratio | 1.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.89, with a Debt / Equity ratio of 0.02.
| Current Ratio | 0.89 |
| Quick Ratio | 0.52 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -45.98 |
Financial Efficiency
Return on equity (ROE) is -100.61% and return on invested capital (ROIC) is -531.54%.
| Return on Equity (ROE) | -100.61% |
| Return on Assets (ROA) | -20.32% |
| Return on Invested Capital (ROIC) | -531.54% |
| Return on Capital Employed (ROCE) | -113.99% |
| Weighted Average Cost of Capital (WACC) | 9.75% |
| Revenue Per Employee | $1.08M |
| Profits Per Employee | -$374,965 |
| Employee Count | 173 |
| Asset Turnover | 1.61 |
| Inventory Turnover | 11.29 |
Taxes
In the past 12 months, PetMed Express has paid $5.69 million in taxes.
| Income Tax | 5.69M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.15% in the last 52 weeks. The beta is 0.78, so PetMed Express's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | -35.15% |
| 50-Day Moving Average | 2.49 |
| 200-Day Moving Average | 2.76 |
| Relative Strength Index (RSI) | 41.19 |
| Average Volume (20 Days) | 80,637 |
Short Selling Information
The latest short interest is 811,886, so 3.80% of the outstanding shares have been sold short.
| Short Interest | 811,886 |
| Short Previous Month | 723,702 |
| Short % of Shares Out | 3.80% |
| Short % of Float | 5.85% |
| Short Ratio (days to cover) | 9.98 |
Income Statement
In the last 12 months, PetMed Express had revenue of $186.96 million and -$64.87 million in losses. Loss per share was -$3.12.
| Revenue | 186.96M |
| Gross Profit | 51.47M |
| Operating Income | -37.84M |
| Pretax Income | -59.18M |
| Net Income | -64.87M |
| EBITDA | -28.81M |
| EBIT | -37.84M |
| Loss Per Share | -$3.12 |
Full Income StatementBalance Sheet
The company has $26.91 million in cash and $652,000 in debt, giving a net cash position of $26.26 million or $1.23 per share.
| Cash & Cash Equivalents | 26.91M |
| Total Debt | 652,000 |
| Net Cash | 26.26M |
| Net Cash Per Share | $1.23 |
| Equity (Book Value) | 32.77M |
| Book Value Per Share | 1.53 |
| Working Capital | -6.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$16.64 million and capital expenditures -$6.28 million, giving a free cash flow of -$22.92 million.
| Operating Cash Flow | -16.64M |
| Capital Expenditures | -6.28M |
| Depreciation & Amortization | 9.03M |
| Net Borrowing | n/a |
| Free Cash Flow | -22.92M |
| FCF Per Share | -$1.07 |
Full Cash Flow StatementMargins
Gross margin is 27.53%, with operating and profit margins of -20.24% and -34.70%.
| Gross Margin | 27.53% |
| Operating Margin | -20.24% |
| Pretax Margin | -31.65% |
| Profit Margin | -34.70% |
| EBITDA Margin | -15.41% |
| EBIT Margin | -20.24% |
| FCF Margin | n/a |